SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers
15 references·0 citing·40 second hop
On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers (2020)On the Use of Markov Models in Pharmacoec…Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research (2016)Country-Level Cost-Effectiven…In Denmark kidney transplantation is more cost-effective than dialysis. (2014)In Denmark kidney transplanta…Median-Based Incremental Cost-Effectiveness Ratio (ICER) (2012)Median-Based Incremental Cost…When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D Study (2009)When is Pharmacogenetic Testi…Probability, Markov Chains, Queues, and Simulation: The Mathematical Basis of Performance Modeling (2009)Probability, Markov Chains, Q…Comparison of Markov Model and Discrete-Event Simulation Techniques for HIV (2009)Comparison of Markov Model an…Modelling Methods for Pharmacoeconomics and Health Technology Assessment (2008)Modelling Methods for Pharmac…Decision Modelling For Health Economic Evaluation (2006)Decision Modelling For Health…Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models (2004)Assessing generalisability by…Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies (2002)Thinking Outside the Box: Rec…Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis (2002)Something old, something new,…An Introduction to Markov Modelling for Economic Evaluation (1998)An Introduction to Markov Mod…Principles of Pharmacoeconomics (1996)Principles of Pharmacoeconomi…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Markov Models in Medical Decision Making (1993)Markov Models in Medical Deci…Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Methods for the economic evaluation of health care programmes (1987)Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data (2003)Generalisability in economic evaluation studies in healthcare: a review and case studies (2004)Methods for the Economic Evaluation of Health Care Programmes (2005)Quality of life and pharmacoeconomics in clinical trials (1996)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)???Lost in Translation??? (2006)Decision-analytical modelling in health-care economic evaluations (2007)The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report (2009)Econometric Analysis of Panel Data (2021)Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations? (2010)The long‐term cost‐effectiveness of obesity prevention interventions: systematic literature review (2012)A review of economic evaluations of behavior change interventions: setting an agenda for research methods and practice (2013)Handbook of Research Methods in Social and Personality Psychology (2014)XXIV. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. In a letter to Francis Baily, Esq. F. R. S. &c (1825)Handling Uncertainty in Cost-Effectiveness Models (2000)A rational framework for decision making by the National Institute For Clinical Excellence (NICE) (2002)A taxonomy of model structures for economic evaluation of health technologies (2006)Deciphering death: a commentary on Gompertz (1825) ‘On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies’ (2015)Costs, effects and C/E‐ratios alongside a clinical trial (1994)Net Health Benefits (1998)Growth and Quality of the Cost–Utility Literature, 1976–2001 (2005)Cost-Effectiveness Analyses of Vaccination Programmes (2008)Regression models for analyzing costs and their determinants in health care: an introductory review (2011)The Value of a Statistical Life: A Critical Review of Market Estimates Throughout the World (2003)Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold (2014)The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought (2016)The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion (2020)Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures (2023)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Review of guidelines for good practice in decision-analytic modelling in health technology assessment (2004)A comparison of the constant-order and dual-index policy for dual sourcing (2010)A perspective on applications of in-memory analytics in supply chain management (2015)A simulation and optimization based method for calibrating agent-based emergency department models under data scarcity (2016)Model Parameter Estimation and Uncertainty Analysis (2012)Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 (2012)Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 (2012)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 2006Decision Modelling For Health Economic Evaluation3,144 cited
  • 1993Markov Models in Medical Decision Making2,411 cited
  • 1998An Introduction to Markov Modelling for Economic Evaluation960 cited
  • 2016Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research889 cited
  • 2002Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis535 cited
  • 2009Probability, Markov Chains, Queues, and Simulation: The Mathematical Basis of Performance Modeling432 cited
  • 2002Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies404 cited
  • 2008Modelling Methods for Pharmacoeconomics and Health Technology Assessment171 cited
  • 2004Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models117 cited
  • 2012Median-Based Incremental Cost-Effectiveness Ratio (ICER)90 cited
  • 2009When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D Study82 cited
  • 2009Comparison of Markov Model and Discrete-Event Simulation Techniques for HIV69 cited
  • 1996Principles of Pharmacoeconomics

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

69 cited
  • 2014In Denmark kidney transplantation is more cost-effective than dialysis.60 cited
  • Cited by

    No citing works inside the corpus for this window.